A treatment by exenatide administered for 6 months in type 2 diabetics improves function better than beta-cell than insulin sensitivity

被引：1
|
作者：
Preumont, V. [1 ]
Hermans, M. P. [1 ]
Brichard, S. [1 ]
Buysschaert, M. [1 ]
机构：
[1] Clin Univ Ucl St Luc, Brussels, Belgium
来源：
DIABETES & METABOLISM | 2010年 / 36卷
关键词：
D O I：
10.1016/S1262-3636(10)70230-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A59 / A59
页数：1
相关论文
共 50 条
  • [1] Exenatide: One year of treatment improves beta-cell function in type 2 diabetics
    Sauvanet, J. -P.
    ANNALES D ENDOCRINOLOGIE, 2007, 68 (06)
  • [2] Six-month exenatide improves HOMA hyperbolic product in type 2 diabetic patients mostly by enhancing beta-cell function rather than insulin sensitivity
    Preumont, V.
    Hermans, M. -P.
    Brichard, S.
    Buysschaert, M.
    DIABETES & METABOLISM, 2010, 36 (04) : 293 - 298
  • [3] Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes
    Sarkar, Gayatri
    Alattar, May
    Brown, Rebecca J.
    Quon, Michael J.
    Harlan, David M.
    Rother, Kristina I.
    DIABETES CARE, 2014, 37 (03) : 666 - 670
  • [4] Orforglipron Improves Markers of Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes
    Rosenstock, Julio
    Robins, Deborah A.
    Duffin, Kevin L.
    Wilson, Jonathan M.
    Mather, Kieren J.
    Banerjee, Hiya
    Lin, Yanzhu
    Eyde, Sarah
    Kazda, Christof M.
    Konig, Manige
    DIABETES, 2024, 73
  • [5] Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes Mellitus
    Sarkar, Gayatri
    Alattar, May
    Brown, Rebecca J.
    Quon, Michael J.
    Harlan, David M.
    Rother, Kristina I.
    DIABETES, 2012, 61 : A17 - A17
  • [6] BETA-CELL FUNCTION DURING INITIAL TREATMENT IN INSULIN DEPENDENT DIABETICS
    KRARUP, T
    MADSBAD, S
    REGEUR, L
    BINDER, C
    FABER, O
    ACTA ENDOCRINOLOGICA, 1979, 91 : 44 - 44
  • [7] Beta-Cell Function Improved in Insulin Deficient Type 2 Diabetics and Insulin Sensitivity Improved in Insulin-Resistant Type 2 Diabetics during Long-Term Insulin Pump Therapy
    Choi, Soo Bong
    Hong, Eun Shil
    Noh, Yun Hee
    DIABETES, 2018, 67
  • [8] PEGylated exenatide injection (PB-119) improves beta-cell function and insulin resistance in treatment-naive type 2 diabetes mellitus patients
    Liu, Xu
    Song, Ling
    Zhang, Yuanhui
    Li, Haiyan
    Cui, Cheng
    Liu, Dongyang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [9] Mechanistic disease progression analysis indicates that pioglitazone improves beta-cell function in treatment-naive type 2 diabetics
    De Winter, W
    Dejongh, J
    Urquhart, R
    Moules, I
    Eckland, D
    Danhof, M
    DIABETES, 2005, 54 : A65 - A65
  • [10] Exenatide : one year of treatment improves the beta-cellular fuction in type 2 diabetics
    Sauvanet, J. -P.
    DIABETES & METABOLISM, 2007, 33 (05)
12345